 |
 |
Blogs about: Decodeme
|
|
|
... genome and what it means for you and your health."
What did this achieve? Well, it took the DTC DeCodeme out of the publicly owned realm. Which is probably a good thing. Let me tell ... of these companies, hoping to innovate his way out of this money pit.
This reason is probably why DeCodeme went private and will likely give up control of their data. They need some sucker to keep pouring money ...
|
|
... London.
DeCODE Genetics, a genetics research firm, began offering personalized DNA testing through its deCODEme website two years ago. A customer mails in a sample taken from the inside of ... firm, has already put in a bid to buy deCODE’s operations, including the deCODEme business, though the sale of the operations must still undergo a public auction.
The company told the Times that Saga ...
|
|
... (SergeandMe) can keep throwing money into the kitty and outlast this economic downturn and premature launch of these companies, hoping to innovate his way out of this money pit.
This reason is probably why DeCodeme went private and will likely give up control of their data. They need some sucker to keep pouring money into a boondoggle that has no exit for at LEAST the next 15 years if at all.
...
|
|
... that may be of interest for genetic hobbyists: it provides instructions on how to run the program STRUCTURE on your own genetic data generated by a personal genomics company such as 23andMe or deCODEme.
STRUCTURE is an extremely popular tool among researchers working in population genetics, which allows you to generate plots showing estimates of the proportion of an individual's genome ...
|
|
... . Not that folks didn't try; Decode even in-licensed a drug and acquired all the pieces for a full drug development capability.
Of course, perhaps Decode's greatest notoriety came from their deCodeMe DTC genetic testing business. Given the competition & controversy in this field, that was unlikely to save them. The Icelandic financial collapse I think did them some serious damage ...
|
|
... is not declaring bankruptcy,
carries out all of deCODE's human genetics work and and provides deCODEme.
We believe this offer provides a firm foundation for continuing to offer you
the same path breaking science and service you expect from deCODEme. Saga is
led by Polaris Venture Partners and Arch Venture Partners, two leading
technology ...
|
|
|
|
 |
 |
|